Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2019

May 14, 2019

SELL
$23.15 - $28.34 $1.54 Million - $1.89 Million
-66,600 Reduced 30.75%
150,000 $3.67 Million
Q2 2018

Aug 14, 2018

SELL
$26.4 - $42.0 $4.83 Million - $7.69 Million
-183,100 Reduced 45.81%
216,600 $8.42 Million
Q1 2018

May 15, 2018

SELL
$18.43 - $28.8 $281,979 - $440,640
-15,300 Reduced 3.69%
399,700 $11 Million
Q3 2017

Nov 14, 2017

BUY
$14.65 - $16.85 $6.08 Million - $6.99 Million
415,000
415,000 $6.7 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $291M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Kingdon Capital Management, L.L.C. Portfolio

Follow Kingdon Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.